Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study

202216 citationsJournal Articlebronze Open Access

Authors

R Naveen · Sanjay Gandhi Post Graduate Institute of Medical Sciences

Elena Nikiphorou · King's College London

Mrudula Joshi · B. J. Medical College & Sassoon Hospital

Parikshit Sen · Maulana Azad Medical College

Julius Lindblom · Karolinska University Hospital

Vishwesh Agarwal · Sanjay Gandhi Post Graduate Institute of Medical Sciences

James B Lilleker

Abstract

While COVID-19 vaccination-related AEs were reported by four-fifths of SLE patients, those were mostly minor and comparable to AEs reported by healthy individuals, providing reassurance regarding COVID-19 vaccination safety in SLE.

Topics & Keywords

Systemic Lupus Erythematosus Research SARS-CoV-2 and COVID-19 Research Heparin-Induced Thrombocytopenia and Thrombosis

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Lara D. Veeken

Volume 62, Issue 7, pp. 2453-2463

DOI: 10.1093/rheumatology/keac661

Field-Weighted Citation Impact: 2.72